Projects per year
Personal profile
Education
- 2011 PhD, Institute of Biopharmaceutical Sciences, National Cheng Kung University
Experience
- 2018/02 ~ present Associate Professor, School of Pharmacy, National Cheng Kung University
- 2018/02 ~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
- 2014/08 ~ 2018/02 Assistant Professor, School of Pharmacy, National Cheng Kung University
- 2013/02 ~ 2018/02 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
- 2011 ~ 2013 Postdoctoral Fellow, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF)
Research Interests
- Pharmacogenomics
- Human Microbiome
- Personalized Medicine
- Bioinformatics
- Clinical pharmacy
Fingerprint Dive into the research topics where Hui-Hua Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Major Depressive Disorder
Medicine & Life Sciences
Bipolar Disorder
Medicine & Life Sciences
Antidepressive Agents
Medicine & Life Sciences
Valproic Acid
Medicine & Life Sciences
C-Reactive Protein
Medicine & Life Sciences
Depression
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Genes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2018
- 6 Finished
補充微量營養素影響抗癲癇藥物之治療成效-影響抗癲癇藥物與綜合維生素補充劑療效之藥物基因體學研究–以維生素B6為例聯結癲癇病人基因型分析與斑馬魚活體測試之前導型研究(1/3)
17-08-01 → 18-07-31
Project: Research project
Research Output 2009 2019
Association between polymorphisms of OCT1 and metabolic response to metformin in women with polycystic ovary syndrome
Chang, H-H., Hsueh, Y. S., Cheng, Y. W., Ou, H-T. & Wu, M-H., 2019 Apr 1, In : International journal of molecular sciences. 20, 7, 1720.Research output: Contribution to journal › Article
Open Access
ovaries
Polycystic Ovary Syndrome
Metformin
polymorphism
Polymorphism
Factors related to metabolic parameters in medicated patients with major depressive disorder––a naturalistic study
Lee, C. J., Lee, L-T., Tsai, H-C., Chang, W-H., Lee, I-H., Chen, K-C., Chang, H-H., Chen, P-S. & Yang, Y-K., 2018 Oct 1, In : Psychiatry Research. 268, p. 28-33 6 p.Research output: Contribution to journal › Article
Major Depressive Disorder
Body Mass Index
Homeostasis
Fingers
Insulin Resistance
2
Citations
(Scopus)
FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate
Chang, H-H., Chen, P-S., Cheng, Y. W., Wang, T-Y., Yang, Y-K. & Lu, R-B., 2018 Apr 1, In : International Journal of Neuropsychopharmacology. 21, 4, p. 319-324 6 p.Research output: Contribution to journal › Article
Valproic Acid
Bipolar Disorder
Therapeutics
Depression
Body Weight
A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate
Chen, P-S., Chang, H-H., Huang, C-C., Lee, C. C., Lee, S. Y., Chen, S. L., Huang, S. Y., Yang, Y-K. & Lu, R-B., 2017 Mar 1, In : Pharmacogenomics Journal. 17, 2, p. 155-161 7 p.Research output: Contribution to journal › Article
Guanine Nucleotides
Protein Subunits
Valproic Acid
Longitudinal Studies
Carrier Proteins
6
Citations
(Scopus)
C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder
Chang, H-H., Wang, T-Y., Lee, I-H., Lee, S. Y., Chen, K-C., Huang, S. Y., Yang, Y-K., Lu, R-B. & Chen, P-S., 2017 Jan 2, In : World Journal of Biological Psychiatry. 18, 1, p. 63-70 8 p.Research output: Contribution to journal › Article
Major Depressive Disorder
Staphylococcal Protein A
Bipolar Disorder
C-Reactive Protein
Biomarkers